Immune effector function

Immune effector function is a broad term describing the biological mechanisms used by the immune system to eliminate pathogens, infected cells, or malignant cells. It is not a single molecular target but a coordinated physiological process involving various cells and proteins, such as natural killer (NK) cells, macrophages, and the complement system (Abbas et al., Cellular and Molecular Immunology, 2021). In the context of pharmacology, many therapeutic monoclonal antibodies are designed to harness these functions—specifically Antibody-Dependent Cellular Cytotoxicity (ADCC), Antibody-Dependent Cellular Phagocytosis (ADCP), and Complement-Dependent Cytotoxicity (CDC)—to destroy target cells (Weiner et al., Nature Reviews Cancer, 2010). These functions are typically triggered when the Fc region of an antibody binds to Fc receptors on immune cells or to the C1q component of the complement cascade (Nimmerjahn & Ravetch, Nature Reviews Immunology, 2008). While essential for the efficacy of many oncology and autoimmune therapies, the overactivation of effector functions can lead to significant safety issues, including cytokine release syndrome and systemic inflammatory responses. Consequently, modern drug engineering often focuses on effector-silent or effector-enhanced antibody variants to tailor the immune response to specific clinical needs (Wang et al., Protein & Cell, 2018).

Other names

Effector responseImmune-mediated cytotoxicityFc-mediated effector functionAntibody-dependent effector functionEffector mechanism

Immune effector functions are mechanisms by which the immune system eliminates targets, primarily through Antibody-Dependent Cellular Cytotoxicity (ADCC), Antibody-Dependent Cellular Phagocytosis (ADCP), and Complement-Dependent Cytotoxicity (CDC). These processes are triggered when the Fc region of an antibody binds to specific Fc receptors (e.g., CD16, CD32, CD64) on effector cells like NK cells and macrophages, or to the C1q protein to initiate the complement cascade.